# Finnova Capital > Finnova Capital is a VC fund backing Manufacturing and Information Technology. See 21 investments, check sizes, portfolio. Updated Aug 2026. - Type: VC Fund - Total investments: 21 - Last investment: Feb 2026 - Lead investor: 19% - Last updated: Aug 2026 Finnova Capital is an investment firm. ## Investment focus ### Industry | Industry | Investments | Share | | --- | --- | --- | | Manufacturing | 11 | 52% | | Information Technology | 4 | 19% | | Medical | 3 | 14% | | Biopharma | 3 | 14% | | Biotechnology | 3 | 14% | 32 industries tracked in total. ### Stage | Stage | Investments | Share | | --- | --- | --- | | Series A | 5 | 24% | | Series B | 5 | 24% | | Seed | 3 | 14% | | Angel | 2 | 10% | | Series C | 2 | 10% | 9 stages tracked in total. ### Country | Country | Investments | Share | | --- | --- | --- | | China | 19 | 90% | | United States | 1 | 5% | ## Investments | Company | Description | Amount | Stage | Date | Website | | --- | --- | --- | --- | --- | --- | | Astathera | Astathera focuses on producing and developing medical nuclides and drugs, offering treatment solutions that integrate disease diagnosis and treatment. | | Series A | Feb 17, 2026 | | | Perception Origin | Perception Origin is a leading domestic supplier of commercial spaceborne payloads, specializing in the development and advancement of Synthetic Aperture Radar (SAR) technology. | | Series A | Nov 11, 2025 | | | Xunsheng Medical | Xunsheng Medical is a biotechnology business that focuses on the research and development of tumor immunotherapy medications. | | Series A | Aug 18, 2025 | | | Saikesais Hydrogen Energy | Saikesais Hydrogen Energy is a developer of PEM hydrogen generation equipment. It focuses on research, development, and application of proton exchange membrane (PEM) hydrogen production technology. | | Seed | Aug 18, 2025 | | | Baoji Pharmaceutical | Baoji Pharmaceutical is a biopharma R&D manufacturer, a Sino-foreign joint biopharmaceutical enterprise integrating drug R&D and production. | | Series C | Dec 01, 2024 | | | Nanok Biotechnology | Nanok is a revolutionary antibacterial medication developer. Its principal products are new antimicrobial peptides, which are primarily utilized to destroy multidrug-resistant bacteria that are resistant to conventional antibiotics. It focuses on addressing the increasingly important issue of bacterial resistance to antimicrobial medicines today. | | Pre-Seed | Nov 22, 2024 | | | Microchip | Microchip specializes in the development of new power semiconductor devices, including lGBT, coolmos, SiC, and intelligent power modules. Its products are used in industrial frequency conversion, new energy vehicles, power generation, energy storage, and white appliances. | | Series B | Aug 26, 2024 | | | Eplus 3d | Eplus 3d is committed to the research and development and promotion of industrial-grade 3D printing (additive manufacturing) systems and application technologies. With MPBF™ metal 3D printing technology as the core, it provides aerospace, high-performance industrial manufacturing, mold manufacturing, and precision Provides professional additivemanufacturing application solutions in medical and other fields. | | Series B | Jul 02, 2024 | | | Mokrypton Intelligence | Mokrypton Intelligence is a power semiconductor packaging and testing solution provider that specializes in the manufacture, research & development, and sales of intelligent, fully automated power semiconductor packaging and testing systems. | | Seed | Feb 20, 2024 | | | Best Ray | Bolui Laser is a high tech enterprises that focuses on independent research and development and industrialization of high-end lasers and laser applications. It offers clients h innovative solutions in the fields of industrial processing, cutting-edge scientific research, environmental monitoring, semiconductors, radar remote sensing, etc. andcompetitive products and advanced laser technology solutions to continue to create value for customers. | | Seed | Sep 15, 2023 | | 10 of 21 investments shown. ## Co-investors - [Center Ventures](https://shizune.co/investors/profile/center-ventures) — VC Fund, 2 deals together - [Lucion](https://shizune.co/investors/profile/lucion) — VC Fund, 2 deals together - [Boxin Capital](https://shizune.co/investors/profile/boxin-capital) — VC Fund, 1 deal together - [Canglan Capital](https://shizune.co/investors/profile/canglan-capital) — VC Fund, 1 deal together - CDHTI Venture Capital — VC Fund, 1 deal together - CHERAMI — VC Fund, 1 deal together ## Similar investors ### Similar stage - [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund - [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund - [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund ## FAQ ### What does Finnova Capital invest in? Finnova Capital invests primarily in Manufacturing, Information Technology and Medical startups, most often at Series A and Series B stage. Most of the 21 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio. ### When did Finnova Capital last invest? The most recent investment recorded for Finnova Capital closed in Feb 2026. Shizune tracks 21 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly. ### Is Shizune's investor data accurate? Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page. # About Shizune Shizune.co is an investor database. Core features: - 48,091 startup investors (angels, VCs, accelerators, and others) - Email, phone, LinkedIn (for intros), socials, and other contact data - Updated daily from public funding news - CSV and Excel export The User can access the full database FOR FREE after signing up: shizune.co